Australia markets closed

The Beauty Health Company (SKIN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
12.87+0.01 (+0.08%)
At close: 04:00PM EDT
12.87 0.00 (0.00%)
After hours: 04:15PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.13B
Enterprise value 2.02B
Trailing P/E N/A
Forward P/E 285.71
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.41
Price/book (mrq)6.24
Enterprise value/revenue 7.02
Enterprise value/EBITDA -6.61

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-31.76%
S&P500 52-week change 3-11.93%
52-week high 330.17
52-week low 39.94
50-day moving average 312.79
200-day moving average 319.05

Share statistics

Avg vol (3-month) 32.04M
Avg vol (10-day) 31.86M
Shares outstanding 5150.63M
Implied shares outstanding 6N/A
Float 8145.4M
% held by insiders 18.04%
% held by institutions 195.47%
Shares short (14 June 2022) 419.67M
Short ratio (14 June 2022) 411.49
Short % of float (14 June 2022) 423.85%
Short % of shares outstanding (14 June 2022) 413.06%
Shares short (prior month 12 May 2022) 417.7M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin -117.84%
Operating margin (ttm)-18.05%

Management effectiveness

Return on assets (ttm)-4.53%
Return on equity (ttm)-219.98%

Income statement

Revenue (ttm)287.96M
Revenue per share (ttm)2.20
Quarterly revenue growth (yoy)58.60%
Gross profit (ttm)181.83M
EBITDA -32.97M
Net income avi to common (ttm)-339.33M
Diluted EPS (ttm)-2.99
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)859.24M
Total cash per share (mrq)5.7
Total debt (mrq)749.1M
Total debt/equity (mrq)219.22
Current ratio (mrq)14.25
Book value per share (mrq)2.27

Cash flow statement

Operating cash flow (ttm)-68.09M
Levered free cash flow (ttm)-50.89M